News

Neural plasticity depends on robot-like carrier molecules to deliver their goods from cell body to synapse, a new study finds.

A gene linked to neurofibromatosis causes widespread metabolic disruption in fruit fly models of the neurological disease.

The Scripps Research scientists are part of a large collaborative team to win the 2021 Robert Robinson Award in Synthetic Organic Chemistry. 

As part of Scripps Research’s landmark DETECT study, scientists are examining physiological and behavioral changes that often last months after a COVID-19 infection. 

New discovery helps explain how disruption to daily biological rhythms, such as long-term rotational shift work, could lead to increased risk of cancer.

Lou brings experience as a biopharma industry leader and a champion for accessible healthcare as she carries on the legacy of life partner John C. Martin.

Protein engineering and autism genetics experts join the faculty, bringing diverse skills and tools.

Shape-shifting catalyst enables powerful, broad method for adding hydroxyl groups.

A grant from the New York-based foundation will fuel expansion of DETECT, Scripps Research’s sensor-based study for real-time digital detection of viral illness.    

Strong immune responses to unchanging, conserved parts of the 2009 pandemic H1N1 flu virus suggest strategies for effective universal influenza vaccines.

FDA-approved drugs or experimental drugs with ample health data could be rapidly tested in humans for treatment of COVID-19.

Pandit will provide leadership and medical oversight for a growing portfolio of digital trials and data science research programs.

The novel drug created at Scripps Research has achieved a second FDA approval, this time for ulcerative colitis, as clinical trials continue for Crohn’s disease.

Scientists from Scripps Research investigated how the immune system’s previous exposure to cold-causing coronaviruses impact immune response to COVID-19. 

The findings provide direction for future vaccines or therapies that may offer broader protection against variants.

Proteins that enable the sense of touch in humans have an evolutionary cousin that helps plants grow their root systems.

A total of 42 graduates are earning PhDs after completing their academic journey at the Skaggs Graduate School of Chemical and Biological Sciences.

The design provides several advantages over standard vaccine approaches for Ebola and related viruses that continue to threaten global health.

Based on the Florida campus of Scripps Research, Renata devises efficient chemical techniques for recreating valuable compounds found in nature.  

Breakthrough research provides a deeper understanding of enzymes that shape many facets of health.  

Blackmond’s discoveries have propelled drug development and shed new light on complex chemistry in the natural world.

Donna Blackmond, Marisa Roberto and Xiang-Lei Yang have been honored with endowed chairs in recognition of their scientific leadership and impactful discoveries.

To create memories, the brain constantly adapts to new information and stores memories by building connections among neurons.

Results are an important step in the development of a broader-acting treatment for Ebola and related viruses.